NASDAQ: ARDXArdelyx Inc Stock Ownership - Who owns Ardelyx?
Insider buying vs selling
Have Ardelyx Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Laura A. Williams | Chief Patient Officer | 2025-08-26 | 30,000 | $6.12 | $183.63kSell |
| Laura A. Williams | Chief Patient Officer | 2025-08-26 | 50,000 | $0.99 | $49.50kBuy |
| Laura A. Williams | Chief Patient Officer | 2025-08-26 | 50,000 | $6.12 | $306.05kSell |
| Michael Raab | President CEO | 2025-08-21 | 45,687 | $5.93 | $271.02kSell |
| Laura A. Williams | Chief Patient Officer | 2025-08-21 | 6,261 | $5.93 | $37.14kSell |
| Elizabeth A. Grammer | Chief Legal and Administrative Officer | 2025-08-21 | 5,841 | $5.93 | $34.65kSell |
| Mike Kelliher | Chief Business Officer | 2025-08-21 | 5,417 | $5.93 | $32.13kSell |
| Justin A. Renz | Chief Financial Officer | 2025-08-21 | 7,037 | $5.93 | $41.74kSell |
| Eric Duane Foster | Chief Commercial Officer | 2025-08-21 | 15,308 | $5.93 | $90.81kSell |
| David M. Mott | Director | 2025-06-16 | 200,000 | $3.63 | $725.80kBuy |
ARDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ARDX insiders and whales buy or sell their stock.
ARDX Shareholders
What type of owners hold Ardelyx Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Krishna Kittu Kolluri | 8.95% | 21,572,475 | $133.53M | Insider |
| Blackrock Inc | 8.61% | 20,747,853 | $128.43M | Institution |
| Peter J. Barris | 7.80% | 18,800,125 | $116.37M | Insider |
| M. James Barrett | 7.44% | 17,921,753 | $110.94M | Insider |
| Patrick J. Kerins | 7.33% | 17,666,935 | $109.36M | Insider |
| Forest Baskett | 6.76% | 16,299,721 | $100.90M | Insider |
| Vanguard Group Inc | 6.65% | 16,031,649 | $99.24M | Institution |
| Janus Henderson Group PLC | 6.25% | 15,057,940 | $93.21M | Institution |
| Scott D. Sandell | 5.69% | 13,709,147 | $84.86M | Insider |
| Nea Partners 12 Limited Partnership | 5.69% | 13,706,135 | $84.84M | Insider |
ARDX vs Biotech Stocks
Ardelyx Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.